Works by Holman, Rury R.
Results: 161
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56695-z
- By:
- Publication type:
- Article
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 5, p. 1, doi. 10.1002/dmrr.3632
- By:
- Publication type:
- Article
Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90).
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14656
- By:
- Publication type:
- Article
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14552
- By:
- Publication type:
- Article
Introduction.
- Published in:
- Diabetic Medicine, 2008, v. 25, p. 1, doi. 10.1111/j.1464-5491.2008.02539.x
- By:
- Publication type:
- Article
Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 9, p. 1017, doi. 10.1007/s40273-024-01398-4
- By:
- Publication type:
- Article
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
- Published in:
- Diabetes Care, 2025, v. 48, n. 2, p. 235, doi. 10.2337/dc24-1455
- By:
- Publication type:
- Article
Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Historical HbA<sub>1c</sub> Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comment on Kim et al. The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks. Diabetes Care 2019;42:3-9.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Editors' Expert Forum.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pancreatic Safety of Sitagliptin in the TECOS Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data.
- Published in:
- Diabetes Care, 2013, v. 36, n. 6, p. 1541, doi. 10.2337/dc12-1120
- By:
- Publication type:
- Article
Evaluation of a Self-Administered Oral Glucose Tolerance Test.
- Published in:
- Diabetes Care, 2013, v. 36, n. 6, p. 1483, doi. 10.2337/dc12-0643
- By:
- Publication type:
- Article
Initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) trial: an interview study of patients' and health professionals' experiences.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Initiating Insulin as part of the Treating To Target in Type 2 Diabetes (4-T) Trial.
- Published in:
- Diabetes Care, 2010, v. 33, n. 10, p. 2178, doi. 10.2337/dc10-0494
- By:
- Publication type:
- Article
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
- Published in:
- 2010
- By:
- Publication type:
- journal article
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain.
- Published in:
- Diabetes Care, 2010, v. 33, n. 1, p. 177, doi. 10.2337/dc09-1661
- By:
- Publication type:
- Article
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort.
- Published in:
- Diabetes Care, 2009, v. 32, n. 4, p. 708, doi. 10.2337/dc08-1918
- By:
- Publication type:
- Article
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Timing of SGLT2i initiation after acute myocardial infarction.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02000-5
- By:
- Publication type:
- Article
Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01802-x
- By:
- Publication type:
- Article
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01603-8
- By:
- Publication type:
- Article
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01555-z
- By:
- Publication type:
- Article
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study.
- Published in:
- Journal of Clinical Hypertension, 2012, v. 14, n. 10, p. 731, doi. 10.1111/j.1751-7176.2012.00687.x
- By:
- Publication type:
- Article